Citation Impact
Citing Papers
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors
2016
Transferrin receptor targeting by de novo sheet extension
2021 StandoutNobel
A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice
2007
Four-component protein nanocages designed by programmed symmetry breaking
2024 StandoutNatureNobel
Treatment of Hemophilia A Using Factor VIII Messenger RNA Lipid Nanoparticles
2020
Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach
2023 StandoutNobel
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Screening Libraries to Discover Molecular Design Principles for the Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers Derived from Plant Phenolic Acids
2023 StandoutNobel
Engineering precision nanoparticles for drug delivery
2020 Standout
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
2016 StandoutNature
Tyrosine sulfation: a modulator of extracellular protein–protein interactions
2000 StandoutNobel
Editing the epigenome: technologies for programmable transcription and epigenetic modulation
2016
The sulfatase gene family
1997
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
Lipid nanoparticles for mRNA delivery
2021 Standout
Expanding the Biologist’s Toolkit with CRISPR-Cas9
2015 StandoutNobel
Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media
2007
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Programmable RNA Tracking in Live Cells with CRISPR/Cas9
2016 StandoutNobel
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
2018 StandoutNobel
CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification
2019 StandoutNobel
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
2014
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
2011 Standout
De novo design of luciferases using deep learning
2023 StandoutNatureNobel
A novel role for 12/15-lipoxygenase in regulating autophagy
2014 StandoutNobel
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
2018 Standout
Upscaling of lentiviral vector production by tangential flow filtration
2005
Evolution of a designed protein assembly encapsulating its own RNA genome
2017 StandoutNatureNobel
Non-viral vectors for gene-based therapy
2014 Standout
Engineering targeted viral vectors for gene therapy
2007
State-of-the-art of the production of retroviral vectors
2004
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells
2004 StandoutNobel
Gene therapy for mucopolysaccharidosis
2007
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Gene therapy for HIV infection: what does it need to make it work?
2006 StandoutNobel
Development and Applications of CRISPR-Cas9 for Genome Engineering
2014 Standout
Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle
2014
Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins
2022
Stem cell clonality and genotoxicity in hematopoietic cells: Gene activation side effects should be avoidable
2004
The thioredoxin antioxidant system
2013 Standout
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering
2016 StandoutNobel
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
2016 Standout
Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors
2009 Standout
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes
2016 StandoutNobel
Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes
2017 StandoutNobel
Thioredoxin-interacting Protein (Txnip) Is a Critical Regulator of Hepatic Glucose Production
2007
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
2019 StandoutNobel
Time-tagged ticker tapes for intracellular recordings
2023 StandoutNobel
Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development
2021 StandoutNobel
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Noninvasive Detection of Lentiviral-Mediated Choline Kinase Targeting in a Human Breast Cancer Xenograft
2009
Fabrication and Characterization of Tumor Nano-Lysate as a Preventative Vaccine for Breast Cancer
2020
Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier
2014
High-Efficiency Gene Transfer into Normal and Adenosine Deaminase-Deficient T Lymphocytes Is Mediated by Transduction on Recombinant Fibronectin Fragments
1998
Chemical and Biophysical Modulation of Cas9 for Tunable Genome Engineering
2016 StandoutNobel
Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity
2019 StandoutNobel
RNA-dependent RNA targeting by CRISPR-Cas9
2018 StandoutNobel
Shining Light on the Secreted Luciferases of Marine Copepods: Current Knowledge and Applications
2018
Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template
2015
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
2014 StandoutNobel
Works of Dao Pan being referenced
Retroviral-Mediated Transfer of the Iduronate-2-Sulfatase Gene into Lymphocytes for Treatment of Mild Hunter Syndrome (Mucopolysaccharidosis Type II). University of Minnesota Medical School, Minneapolis, Minnesota
1996
Secreted Luciferase for In Vivo Evaluation of Systemic Protein Delivery in Mice
2012
Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human α-l-iduronidase gene
2004
Closed hollow-fiber bioreactor: a new approach to retroviral vector production
1999
Intraosseous Delivery of Lentiviral Vectors Targeting Factor VIII Expression in Platelets Corrects Murine Hemophilia A
2015
Biodistribution and Toxicity Studies of VSVG-Pseudotyped Lentiviral Vector after Intravenous Administration in Mice with the Observation of in Vivo Transduction of Bone Marrow
2002
Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I
2000
Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood–brain barrier
2013